Literature DB >> 9222207

Heterogeneous clinical presentation of the mtDNA NARP/T8993G mutation.

F M Santorelli1, K Tanji, S Shanske, S DiMauro.   

Abstract

To obtain a better molecular definition of patients with syndromic retinitis pigmentosa, we screened for mitochondrial DNA (mtDNA) alterations of the two ATPase genes and 22 tRNA-coding sequences in 10 patients whose features resembled NARP (neuropathy, ataxia, and retinitis pigmentosa) syndrome. In two patients, one of whom showed features mimicking Kearns-Sayre syndrome, we identified a heteroplasmic T8993G mutation (average 80%) in the mitochondrial ATPase 6 gene. There was no mutated mtDNA in muscle and leukocytes from the mother of one patient or in leukocytes from his brother, suggesting a rapid segregation of the mutated nucleotide. MtDNA analysis should be considered in the differential diagnosis of patients with syndromic retinitis pigmentosa.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222207     DOI: 10.1212/wnl.49.1.270

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993.

Authors:  S L White; V R Collins; R Wolfe; M A Cleary; S Shanske; S DiMauro; H H Dahl; D R Thorburn
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or age-related variation.

Authors:  S L White; S Shanske; J J McGill; H Mountain; M T Geraghty; S DiMauro; H H Dahl; D R Thorburn
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

Review 3.  Modeling mitochondrial encephalomyopathy in Drosophila.

Authors:  Michael J Palladino
Journal:  Neurobiol Dis       Date:  2010-05-21       Impact factor: 5.996

4.  Bayesian network and mechanistic hierarchical structure modeling of increased likelihood of developing intractable childhood epilepsy from the combined effect of mtDNA variants, oxidative damage, and copy number.

Authors:  Brenda Luna; Sanjiv Bhatia; Changwon Yoo; Quentin Felty; David I Sandberg; Michael Duchowny; Ziad Khatib; Ian Miller; John Ragheb; Jayakar Prasanna; Deodutta Roy
Journal:  J Mol Neurosci       Date:  2014-07-16       Impact factor: 3.444

Review 5.  Mitochondrial disease in childhood: mtDNA encoded.

Authors:  Russell P Saneto; Margret M Sedensky
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

6.  Extremely high mutation load of the mitochondrial 8993 T>G mutation in a newborn: implications for prognosis and family planning decisions.

Authors:  Claudine De Praeter; Arnaud Vanlander; Piet Vanhaesebrouck; Joél Smet; Sara Seneca; Petra De Sutter; Rudy Van Coster
Journal:  Eur J Pediatr       Date:  2014-07-10       Impact factor: 3.183

7.  Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model.

Authors:  Riikka H Hämäläinen; Tuula Manninen; Hanna Koivumäki; Mikhail Kislin; Timo Otonkoski; Anu Suomalainen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

Review 8.  MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis.

Authors:  Ying-Han R Hsu; Haran Yogasundaram; Nirmal Parajuli; Lucas Valtuille; Consolato Sergi; Gavin Y Oudit
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

Review 9.  Mitochondrial genome changes and neurodegenerative diseases.

Authors:  Milena Pinto; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2013-11-16

10.  The ATP-sensitive K channel is seizure protective and required for effective dietary therapy in a model of mitochondrial encephalomyopathy.

Authors:  Keri J Fogle; J Ian Hertzler; Joy H Shon; Michael J Palladino
Journal:  J Neurogenet       Date:  2016-11-21       Impact factor: 1.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.